Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Pediatr Blood Cancer. 2019 Mar 7;66(6):e27681. doi: 10.1002/pbc.27681

Figure 2. The number of red blood cell transfusions received from the date of the first dose of daunorubicin up to 14 days after the second dose was not affected by G6PD status.

Figure 2

The mean (SD) number of red blood cell transfusions were 4.2 (2.7) in patients with deficient G6PD activity and was 3.9 (2.8) in patients with normal G6PD activity (p = 0.73, by multivariable Poisson regression analysis).